SQ-Kyrin TMVr FIM Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SQ-Kyrin TMVr FIM Study — Stella

Home/Mitral Regurgitation/

View on ClinicalTrials.gov

Recruiting

Back to Mitral Regurgitation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

General Hospital of Northern Theater Command, PLA, Shenyang, Liaoning

Key details

Sponsor

Shanghai Shenqi Medical Technology Co., Ltd

Enrollment target

~20 participants

Started

April 2021

Primary completion

October 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.